BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Gross Margin 2022–2025
Current and historical gross margin for BioXcel Therapeutics, Inc. (BTAI) over the last 10 years. The current gross profit margin for BioXcel Therapeutics, Inc. as of December 31, 2025 is 74.45%.
From: 12/31/2022To: 12/31/2025
Revenue
Gross Profit
Gross Margin
BioXcel Therapeutics, Inc. Gross Margin — FAQ
BioXcel Therapeutics, Inc. (BTAI) gross margin over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is BioXcel Therapeutics, Inc.'s gross margin?
BioXcel Therapeutics, Inc. (BTAI) reported gross margin of 74.5% for fiscal 2025.
Where can I see BTAI's gross margin history?
The chart and table above show BioXcel Therapeutics, Inc.'s gross margin by year and by quarter, including the growth rate.